Skip to content

Suspected abacavir hypersensitivity less likely to be diagnosed in people of African ethnicity

HIV prevalence among young women in Botswana falls to lowest level since early 1990s, but still high

No lipid increase with Merck integrase inhibitor at 24 weeks

No fat loss with tenofovir after five years

Botswana mounts one of the most successful national responses to HIV/AIDS — but can it maintain the momentum?

South Africa: authorities rush to control illegal medicines boom

Study challenges current thinking regarding viral load as a predictor of CD4 cell loss

Kaletra dose may need to rise in late pregnancy

Tibotec announces expanded access programme for new NNRTI TMC125